Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
VEEA vs NIVF: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
VEEA Captures Overall Composite Edge (47.7 HOLD vs 46.4 HOLD), While NIVF Leads 3–1 on Growth & Valuation Pillars
VEEA Overall Winner
6-Pillar Tally: VEEA 1 – 3 NIVF (2 Tie)
Matrix Metrics: VEEA 5 – 3 NIVF
As of Nov 16, 2026, Veea Inc. (VEEA) captures the overall head-to-head institutional edge over NewGenIvf Group Limited Class A (NIVF) on higher Unified Composite conviction (47.7/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale), while NIVF wins 3–1 across the 6-pillar growth and valuation breakdown. VEEA trades at $4.78 (N/M Forward P/E, -3873.7% operating margin) versus NIVF at $0.20 (N/M Forward P/E, -238.2% operating margin).
- Growth vs. Quality Trade-Off: VEEA earns the overall head-to-head edge with a stronger Unified Composite Score (47.7/100 HOLD vs. NIVF 46.4/100 HOLD) and -2.32β · 136% Vol risk profile, whereas NIVF leads top-line expansion (-4.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile NIVF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About VEEA vs NIVF
VEEA
Head-to-Head Winner
Veea Inc. Common Stock
$4.78
+6.46% 1D
Market Cap
$18.3M
TTM Revenue
$491,488
Forward P/E
N/M
Beta / 30D Vol
-2.32β · 136% Vol
Unified Composite Score
47.7
HOLD
Tech 40.0
Fund 48.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markup · Hold / add on dips
NIVF
NewGenIvf Group Limited Class A ordinary shares
$0.20
-11.33% 1D
Market Cap
$369,508
TTM Revenue
$4.6M
Forward P/E
N/M
Beta / 30D Vol
0.07β · 3093% Vol
Unified Composite Score
46.4
HOLD
Tech 50.0
Fund 48.0
Flow 50.0
Mom 45.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (VEEA 1 – 3 NIVF)
1. Valuation Multiples
NIVF
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
62.7x
0.1x
2. Growth & Scale
VEEA
Revenue Growth (YoY)
+141.6%
-4.7%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$491,488
$4.6M
Market Cap
$18.3M
$369,508
3. Profitability & Quality
NIVF
Gross Margin
74.3%
23.9%
Operating Margin
-3873.7%
-238.2%
Net Profit Margin
0.0%
24.2%
Return on Equity (ROE)
0.0%
5.5%
4. Balance Sheet & Cash Flow
NIVF
Cash Generation (TTM)
-$19M
-$11M EBITDA
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$13M Net Debt (1.67x D/E)
$733.75 Book/Sh · 5.5% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Information Technology Services Operator
Medical Care Facilities Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: VEEA (5) vs NIVF (3)| Institutional Metric | VEEA | NIVF | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $18.3M | $369,508 | VEEA | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +141.6% | -4.7% | VEEA | |
| Operating Margin (TTM) | -3873.7% | -238.2% | NIVF | |
| Net Profit Margin | 0.0% | 24.2% | NIVF | |
| Return on Equity (ROE) | 0.0% | 5.5% | NIVF | |
| 52-Week Range Position | 53% ($0–$9) | 5% ($0–$3) | VEEA | |
| Beta / 30D Volatility | -2.32β · 136% Vol | 0.07β · 3093% Vol | VEEA | |
| Unified Institutional Score | 47.7 / 100 (HOLD) | 46.4 / 100 (HOLD) | VEEA | |
| Trailing 12M Revenue (USD) | $491,488 | $4.6M | Scale | |
| Gross Profit Margin (TTM) | 74.3% | 23.9% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 62.7x EV/Rev | N/M PEG · 0.1x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$19M ($13M Net Debt (1.67x D/E)) | -$11M EBITDA ($733.75 Book/Sh · 5.5% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
VEEA +40.06 pp
3M Horizon
VEEA +3404.01 pp
6M Horizon
VEEA +778.83 pp
1Y Horizon
VEEA +781.23 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VEEA Revenue | NIVF Revenue | VEEA Op. Margin | NIVF Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2021 | N/A | $0M | N/A | 4.8% | NIVF |
| FY2022 | N/A | $10M | N/A | 6.7% | NIVF |
| FY2023 | $10M | $10M | -114.2% | 0.8% | NIVF |
| FY2024 | $0M | $10M | -59309.8% | -21.4% | NIVF |
| FY2025 | $0M | $0M | -8483.7% | -226.9% | NIVF |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
VEEA
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact VEEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
NIVF
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact NIVF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
VEEA Moat Profile
Cyclical / Execution-Driven Positioning
Information Technology Services Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
NIVF Moat Profile
Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ VEEA vs NIVF Key Questions & Quantitative Answers
As of Nov 16, 2026, Veea Inc. (VEEA) captures the overall head-to-head institutional edge over NewGenIvf Group Limited Class A (NIVF) on higher Unified Composite conviction (47.7/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale), while NIVF wins 3–1 across the 6-pillar growth and valuation breakdown. VEEA trades at $4.78 (N/M Forward P/E, -3873.7% operating margin) versus NIVF at $0.20 (N/M Forward P/E, -238.2% operating margin). Growth vs. Quality Trade-Off: VEEA earns the overall head-to-head edge with a stronger Unified Composite Score (47.7/100 HOLD vs. NIVF 46.4/100 HOLD) and -2.32β · 136% Vol risk profile, whereas NIVF leads top-line expansion (-4.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile NIVF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VEEA leads the Growth & Scale pillar: VEEA posts +141.6% YoY revenue growth and +0.0% YoY earnings growth on $491,488 TTM revenue (74.3% gross margin, -3873.7% operating margin), compared with NIVF at -4.7% YoY revenue growth and +0.0% YoY earnings growth on $4.6M TTM revenue (23.9% gross margin, -238.2% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), VEEA cumulative revenue shifted N/A while NIVF shifted +0.0%. In operating R&D and SG&A reinvestment, VEEA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NIVF.
NIVF screens cheaper on headline valuation multiples. VEEA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 62.7x EV/Revenue (unreported FCF margin), whereas NIVF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VEEA (0.0% ROE) versus NIVF (5.5% ROE) capital efficiency.
In options market volatility and institutional positioning, VEEA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.32β · 136% Vol realized risk). By comparison, NIVF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.07β · 3093% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
NIVF vs VEEA · Reverse Pair
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal